The Green Rush is real. From lawmakers and investment bankers, to CEOs and investors, we will look at how people are transforming cannabis from the shadows of the illicit market into a cash crop that draws in entrepreneurs from Hollywood to Wall Street. Hosts Lewis Goldberg and Anne Donohoe help you navigate the business of cannabis.
All content for The Green Rush is the property of The Green Rush and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Green Rush is real. From lawmakers and investment bankers, to CEOs and investors, we will look at how people are transforming cannabis from the shadows of the illicit market into a cash crop that draws in entrepreneurs from Hollywood to Wall Street. Hosts Lewis Goldberg and Anne Donohoe help you navigate the business of cannabis.
Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.
Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.
We sat down with Lou Reese, co-founder and Vice Chairman of Vaxxinity, a purpose-driven biotechnology company pioneering a new class of medicines aimed at disrupting existing treatments for chronic diseases. Founded in 2014 alongside his wife and CEO, Mei Mei Hu, Vaxxinity is at the forefront of developing "next generation" vaccines for chronic conditions such as Alzheimer's, Parkinson's, heart disease, and migraine.
Lou Reese also serves on the Executive Committee of United Biomedical, Inc. (UBI), a multinational biopharmaceutical organization focused on developing diagnostics and immunotherapeutics for global health improvement. Lou was a director at ShenLian Biotech, one of the largest animal health companies in China, and co-founded an investment firm with ventures spanning real estate, energy, hospitality, and life sciences.
Podcast Highlights:
Introduction & Lou Reese's Background (3:00): Lou's journey and his mission to eliminate global suffering.
Synthetic Peptide Technology (10:15): Discussion of Vaxxinity's innovative approach to vaccine development.
Active Immunotherapy Medicines (18:30): Vaxxinity's work on developing active immunotherapy medicines.
Parkinson's Disease Breakthrough (23:45): Promising results from Vaxxinity's Parkinson's trials.
Company Restructuring (32:00): Vaxxinity's decision to delist and deregister, and plans for becoming a B Corp.
Army of Compassion (41:30): Global prevention trial for Alzheimer's and partnership with former Governor David Beasley.
Future of Healthcare (48:45): Lou's vision for affecting billions of lives and revolutionizing healthcare spending.
Vaxxinity's official website: https://www.vaxxinity.com/
World Food Programme: https://www.wfp.org/
Mayo Clinic: https://www.mayoclinic.org/
UT Health: https://www.uthscsa.edu/
Amprion: https://www.amprionme.com/
United Therapeutics: https://www.unither.com/
Show Credits:
This episode was hosted by Lewis Goldberg of KCSA Strategic Communications.
Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.
You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing AltSpeaking@kcsa.com. You can also connect with us via our social channels:
The Green Rush is real. From lawmakers and investment bankers, to CEOs and investors, we will look at how people are transforming cannabis from the shadows of the illicit market into a cash crop that draws in entrepreneurs from Hollywood to Wall Street. Hosts Lewis Goldberg and Anne Donohoe help you navigate the business of cannabis.
